You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sorafenib

Showing 1076 - 1094 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Taipei (Sorafenib, tegafur/uracil (UFUR®))

Completed
  • Hepatocellular Carcinoma
  • Sorafenib
  • tegafur/uracil (UFUR®)
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 6, 2009

Gastric Cancer Trial in ShangHai (sorafenib)

Terminated
  • Gastric Cancer
  • sorafenib
  • ShangHai, Shanghai, China
    Fudan University Cancer Hospital
Jul 6, 2009

Acute Myeloid Leukemia Trial in Germany (Sorafenib, Placebo)

Completed
  • Acute Myeloid Leukemia
  • Sorafenib
  • Placebo
  • Berlin, Germany
  • +17 more
Aug 18, 2009

Carcinoma, Renal Cell Trial in Birmingham, Scottsdale, Lebanon (rIL-21 only, rIL-21 + sorafenib)

Completed
  • Carcinoma, Renal Cell
  • rIL-21 only
  • rIL-21 + sorafenib
  • Birmingham, Alabama
  • +2 more
May 26, 2009

Thyroid Cancer Trial in Leiden (Sorafenib (nexavar))

Completed
  • Thyroid Cancer
  • Sorafenib (nexavar)
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 22, 2009

Metastatic Disease, Renal Cell Carcinoma Trial in Milano (Nexavar (Sorafenib), IL-2)

Completed
  • Metastatic Disease
  • Renal Cell Carcinoma
  • Nexavar (Sorafenib)
  • IL-2
  • Milano, Italy
    Istituto Tumori
Feb 25, 2009

Prostate Cancer Trial in Pisa (Sorafenib (Nexavar), Docetaxel)

Completed
  • Prostate Cancer
  • Pisa, Italy
    Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologi
Feb 25, 2009

Hepatocellular Carcinoma Trial in Pisa (Infusional 5-Fluorouracil, Sorafenib (Bay 43-9006))

Completed
  • Hepatocellular Carcinoma
  • Infusional 5-Fluorouracil
  • Sorafenib (Bay 43-9006)
  • Pisa, Italy
    Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologi
Feb 25, 2009

Adrenocortical Carcinoma Trial in Italy (Sorafenib, Paclitaxel)

Unknown status
  • Adrenocortical Carcinoma
  • Orbassano, Italy
  • +4 more
Feb 23, 2009

NSCLC Trial in Amsterdam, Groningen, Maastricht (sorafenib + erlotinib)

Unknown status
  • Non-Small Cell Lung Cancer
  • sorafenib + erlotinib
  • Amsterdam, Netherlands
  • +3 more
Mar 2, 2009

Hepatocellular Carcinoma Trial in Rawalpindi (sorafenib, Gemcitabine)

Unknown status
  • Hepatocellular Carcinoma
  • Rawalpindi, Punjab, Pakistan
    Combined Military Hospital
Feb 13, 2009

Kidney Diseases Trial (Sorafenib (BAY43-9006, Nexavar))

Completed
  • Kidney Diseases
  • Sorafenib (BAY43-9006, Nexavar)
  • (no location specified)
Jan 15, 2009

Carcinoma, Renal Cell Trial in Spain (Gemcitabine, Capecitabine and Sorafenib (6 cycles))

Completed
  • Carcinoma, Renal Cell
  • Gemcitabine, Capecitabine and Sorafenib (6 cycles)
  • Barcelona, Spain
  • +9 more
Jan 13, 2009

Testicular Cancer Trial in Warsaw (sorafenib)

Unknown status
  • Testicular Cancer
  • sorafenib
  • Warsaw, Poland
    Chemotherapy Unit, Dept of Urology, Instituite of Oncology
Oct 23, 2008

Metastatic Breast Cancer Trial in Montreal (Sorafenib and Vinorelbine)

Unknown status
  • Metastatic Breast Cancer
  • Sorafenib and Vinorelbine
  • Montreal, Quebec, Canada
    Jewish General Hospital
Oct 17, 2008

Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial in Hong Kong (Sorafenib with Capecitabine and

Unknown status
  • Advanced Hepatocellular Carcinoma
  • Metastatic Hepatocellular Carcinoma
  • Sorafenib with Capecitabine and Oxaliplatin
  • Hong Kong, China
    Queen Mary Hospital
Sep 12, 2008

Locally Advanced Pancreatic Cancer Trial in Italy (Sorafenib 400 mg po bid, continuously, Gemcitabina, Cisplatino)

Unknown status
  • Locally Advanced Pancreatic Cancer
  • Sorafenib 400 mg po bid, continuously
  • Gemcitabina, Cisplatino
  • Treviglio, Bergamo, Italy
  • +16 more
Oct 9, 2008

Hepatocellular Carcinoma Trial in Taipei (3DCRT or IMRT)

Unknown status
  • Hepatocellular Carcinoma
  • 3DCRT or IMRT
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 13, 2009

Soft Tissue Sarcoma Trial in Madrid (Sorafenib)

Unknown status
  • Soft Tissue Sarcoma
  • Sorafenib
  • Madrid, Spain
    Grupo Geis
May 8, 2008